Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 206.627 million compared to CNY 297.072 million a year ago. Operating loss was CNY 56.706 million compared to operating Income of CNY 44.906 million a year ago. Net loss was CNY 40.518 million compared to net income of CNY 50.680 million a year ago. Basic loss per share from continuing operations was CNY 0.3327 compared to basic earnings per share from continuing operations of CNY 0.4162 a year ago.